FDA Recalls Dr. King's SafeCare Rx Female Enhancer Due to Microbial Contamination
King Bio Inc. is recalling Dr. King's SafeCare Rx Female Enhancer due to microbial contamination. The product was distributed in the U.S., Canada, and Australia.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class I, which indicates a reasonable probability that use of the product will cause serious adverse health consequences or death. Per the rubric, FDA Class I recalls are assigned a score of 4 or higher.
Plain-English summary
King Bio Inc. is recalling 114 bottles of Dr. King's SafeCare Rx Female Enhancer, 2 fl. oz. (59 mL), due to microbial contamination. The product is identified by NDC 57955-0115-2 and UPC 357955011521.
The affected lots are 060316A (Expiration 06/19) and 120116A (Expiration 12/19). The product was distributed nationwide in the United States, as well as in Canada and Australia.
Consumers should stop using the product and contact King Bio Inc. for further instructions or a refund.
The recalled product
- Product
- Dr. King's SafeCare Rx Female Enhancer, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955011521, NDC 57955-0115-2
- Manufacturer
- King Bio Inc.
- Category
- Drug — Supplement
- Hazard
- Affected units
- 114
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 060316A Exp. 06/19
- 120116A Exp. 12/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 465 recalled by King Bio Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 465 products in this recall →Related recalls
Same manufacturer · King Bio Inc.
See all →- CriticalKing Bio Recalls Dr. King's SafeCare Rx Calloused Due to Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Spray Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalKing Bio Recalls Heartburn Relief for Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Product Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalDr. King's Advanced Arnica Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereRXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SevereRed Mountain Compounding Recalls S-Hydroxocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- SevereFDA Recalls PGE Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-15
- SevereRXQ Compounding Recalls Cyanocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- ModerateHealthmaxx Recalls Stem Cell Enhance Supplements Due to Mislabeling
FDA (Food) · 2013-10-02
- SevereRXQ Compounding Recalls Lidocaine Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-14